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The estimation of covariance matrices of gene expressions has
many applications in cancer systems biology. Many gene expression
studies, however, are hampered by low sample size and it has there-
fore become popular to increase sample size by collecting gene expres-
sion data across studies. Motivated by the traditional meta-analysis
using random effects models, we present a hierarchical random co-
variance model and use it for the meta-analysis of gene correlation
networks across 11 large-scale gene expression studies of diffuse large
B-cell lymphoma (DLBCL). We suggest to use a maximum likeli-
hood estimator for the underlying common covariance matrix and
introduce an EM algorithm for estimation. By simulation experi-
ments comparing the estimated covariance matrices by cophenetic
correlation and Kullback-Leibler divergence the suggested estimator
showed to perform better or not worse than a simple pooled estima-
tor. In a posthoc analysis of the estimated common covariance matrix
for the DLBCL data we were able to identify novel biologically mean-
ingful gene correlation networks with eigengenes of prognostic value.
In conclusion, the method seems to provide a generally applicable
framework for meta-analysis, when multiple features are measured
and believed to share a common covariance matrix obscured by study
dependent noise.
1. Introduction. Human cells carry out their function in concerted
interaction via intricate protein signalling networks. These networks are ac-
cording to the central dogma of molecular biology controlled by expressed
genes. It has become popular to perform genome wide measurements of ex-
pressed genes and proteins and summarizing the information by huge covari-
ance matrices leading to improved understanding of disease pathology and
identification of new drug targets (Agnelli et al., 2011; Clarke et al., 2013).
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2 A. BILGRAU ET AL.
Many gene expression studies, however, are hampered by low sample size
and it has therefore become of interest to increase sample size by collecting
gene expression data across studies. These data are potentially hampered by
severe batch effects, and robust methods are therefore required to conduct
meta-analysis of covariance matrices.
To the best of our knowledge no approaches exist where meta-analysis of
covariance matrices have been addressed explicitly. We acknowledge, how-
ever, that a number of indirect methods have been constructed. An imme-
diate and tempting approach is to use one of the many study correcting
approaches scattered around in the literature (Irizarry et al., 2003; Johnson,
Li and Rabinovic, 2007; Lee, Dobbin and Ahn, 2014) followed by estimat-
ing the covariance matrix either based on a pooled data set or by pooling
covariance matrices estimated from each individual study as suggested by
Lee, Dobbin and Ahn (2014). This approach, however, suffers from the same
disadvantages as usual meta-analysis based on pooling fixed effects as it puts
too much weight on large outliers in the data (Borenstein et al., 2010).
Motivated by the alternative meta-analysis by random effects (DerSimo-
nian and Laird, 1986; Choi et al., 2003), we suggest a hierarchical model
where the covariance for each study is assumed to be drawn from an inverse
Wishart distribution with a common mean covariance matrix, and data from
each study is then subsequently generated from a multivariate Gaussian dis-
tribution with this covariance matrix. We suggest to use a maximum likeli-
hood estimator for the underlying common covariance matrix and introduce
an EM algorithm for its estimation. We use the method for the meta-analysis
of gene correlation networks across 11 large-scale gene expression studies of
diffuse large B-cell lymphoma (DLBCL). It is our expectation that a more
suitable handling of the covariance matrix will lead to more adequate esti-
mations of covariance matrices and subsequently inferred gene correlation
networks.
In Section 2, we propose the model for a common covariance matrix across
multiple studies, derive estimators thereof, and propose an inter-study ho-
mogeneity measure to aid in assessing the variation between studies. We
conduct an extensive simulation study in Section 3 comparing the proposed
estimator and simple pooling of covariance matrices. We then apply the
model in Section 4 to 2,046 DLBCL samples across 11 datasets before con-
cluding the manuscript in Section 5.
2. A hierarchical model for the covariance matrix. Let p be the
number of features and k the number of studies. We model an observation
x from the i’th study as a p-dimensional zero-mean multivariate Gaussian
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vector with covariance matrix realized from an inverse Wishart distribution,
i.e. x follows the hierarchical model
Σi ∼ W−1p
(
Ψ, ν
)
,
x|Σi ∼ Np(0p,Σi), i = 1, ..., k,
(2.1)
where Np(µ,Σi) denotes a p-dimensional multivariate Gaussian distribu-
tion with mean µ and positive definite (p.d.) covariance matrix Σi, and
probability density function (pdf) shown in (B.1), and W−1p (Ψ, ν) denotes
a p-dimensional inverse Wishart distribution with ν > p− 1 degrees of free-
dom, a p.d. p× p scale matrix Ψ, and pdf shown in (B.2). While the inverse
Wishart distribution is defined for all ν > p − 1, the first order moment
exists only when ν > p+ 1 and is given by
E[Σi] = Σ =
Ψ
ν − p− 1 for ν > p+ 1.(2.2)
Hence, in the Random Covariance Model (RCM) of (2.1), Σ can be inter-
preted as a location-like parameter as it is the expected covariance matrix
in each study. The parameter ν inversely controls the inter-study variation
and can as such be considered an inter-study homogeneity parameter of the
covariance structure. A large ν corresponds to high study homogeneity and
vice versa for small ν. This can further be seen as Σi concentrates around
Σ for ν → ∞ which corresponds to a vanishing inter-study variation for
increasing ν. This fact is seen directly from variance and covariance ex-
pressions for the inverse Wishart (see (F.2) and (F.3)) where the 4th order
denominator grows much faster than the 1st order nominator as polynomials
in ν and causing the variance to vanish for ν → ∞. Thus, the true under-
lying covariance matrix Σ and the homogeneity parameter ν are the effects
of interest to be estimated.
2.1. The likelihood function. Suppose xi1, . . . ,xini are ni i.i.d. observa-
tions from i = 1, ..., k independent studies from the model given in (2.1).
Let Xi = (xi1, . . . ,xini)
> be the ni × p matrix of observations for the i’th
study where rows correspond to samples and columns to variables. By the
independence assumptions, the log-likelihood for Ψ and ν is given by
`
(
Ψ, ν
∣∣X1, ...,Xk) = log f(X1, ...,Xk∣∣Ψ, ν)
= log
∫
f(X1, ...,Xk|Σ1, ...,Σk,Ψ, ν)f(Σ1, ...,Σk|Ψ, ν)dΣ1 · · · dΣk
= log
k∏
i=1
∫
f(Xi|Σi)f(Σi|Ψ, ν)dΣi.
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Throughout, we use the generic notation f(·|·) and f(·) for the conditional
and unconditional pdf of random variables, respectively. Since the inverse
Wishart distribution is conjugate to the multivariate Gaussian distribu-
tion, the integral—of which the integrand forms a Gaussian-inverse-Wishart
distribution—can be evaluated. Hence Σi can be marginalized out, cf. (B.4)
in Appendix B, and we arrive at the following expression for the log-likelihood
function,
`
(
Ψ, ν
∣∣X1, ...,Xk) = log k∏
i=1
∣∣Ψ∣∣ ν2 Γp(ν+ni2 )
pi
nip
2
∣∣Ψ +X>i Xi∣∣ ν+ni2 Γp(ν2)
=
k∑
i=1
[
ν
2
log
∣∣Ψ∣∣− ν + ni
2
log
∣∣Ψ +X>i Xi∣∣+ log Γp(ν+ni2 )Γp(ν2)
]
,(2.3)
up to an additive constant where Γp is the multivariate generalization of
the gamma function Γ, see (B.3). The scatter matrix Si = X
>
i Xi and
study sample size ni are sufficient statistics for each study. Note that Si is
conditionally Wishart distributed, Si|Σi ∼ W(Σi, ni), by construction.
As stated in the following two propositions, the likelihood is not log-
concave in general. However, it is log-concave as a function of ν. All proofs
have been deferred to Appendix C.
Proposition 1 (Non-concavity in Ψ). For a fixed ν, the log-likelihood
function (2.3) is not concave in Ψ.
Proposition 2 (Concavity in ν). For a fixed positive definite Ψ, the
log-likelihood function (2.3) is concave in ν.
While the likelihood function is not concave in Ψ we are able to show the
existence and uniqueness of a global maximum in Ψ.
Proposition 3 (Existence and uniqueness). The log-likelihood (2.3) has
a unique maximum in Ψ for fixed ν and n• =
∑k
a=1 na ≥ p.
In the following section estimators of the parameters are derived using
moments and the EM algorithm assuming ν to be fixed.
2.2. Moment estimator. The pooled empirical covariance matrix can be
viewed as a moment estimator of Σ. By the model assumptions, the first
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and second moment of the j’th observation in the i’th study, xij , is given
by E[xij ] = 0p and
E[xijx>ij ] = E
[
E[xijx>ij |Σi]
]
= E[Σi] =
Ψ
ν − p− 1 = Σ.
for all j = 1, ..., ni and i = 1, ..., k. This suggests the estimators
Ψˆpool = (ν − p− 1)
∑k
i=1 Si∑k
i=1 ni
and Σˆpool =
∑k
i=1 Si∑k
i=1 ni
, ν > p+ 1(2.4)
where the latter is obtained by plugging Ψˆpool into (2.2). This is the well-
known pooled empirical covariance matrix.
2.3. Maximization using the EM algorithm. Here the updating scheme of
the expectation-maximization (EM) algorithm (Dempster, Laird and Rubin,
1977) for fixed ν is derived. We now compute the expectation step of the
EM-algorithm.
From (2.1) we have that,
Σi ∼ W−1p
(
Ψ, ν
)
,
Si|Σi ∼ Wp(Σi, ni) for i = 1, ..., k.
Let ∆i = Σ
−1
i be the precision matrix and let Θ = Ψ
−1, then we equiva-
lently have that
∆i ∼ Wp
(
Θ, ν
)
,
Si|∆i ∼ Wp(∆−1i , ni).(2.5)
From the conjugacy of the inverse Wishart and the Wishart distribution,
the posterior distribution of the precision matrix is
∆i|Si ∼ Wp
((
Θ−1 + Si
)−1
, ni + ν
)
.
Hence, by the expectation of the Wishart distribution,
E[∆i|Si] = (ni + ν)
(
Θ−1 + Si
)−1
.
The maximization step, in which the log-likelihood `(Θ|∆1, ...,∆k) is maxi-
mized, yields the estimate Θˆ = 1kν
∑k
i=1 ∆i, which is the mean of the scaled
precision matrices 1ν∆i (derived in Appendix D). Let Θˆ(t) be the current
estimate of Θ. This yields the updating scheme
Θˆ(t+1) =
1
kν
k∑
i=1
(ni + ν)
(
Θˆ
−1
(t) + Si
)−1
(2.6)
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Algorithm 1 RCM coordinate ascent estimation procedure
1: Input:
2: Sufficient data: (S1, n1), ..., (Sk, nk)
3: Initial parameters: Ψˆ(0), νˆ(0)
4: Convergence criterion: ε > 0
5: Output:
6: Parameter estimates: Ψˆ, νˆ
7: procedure fitRCM(S1, ...,Sk, n1, ..., nk, Ψˆ(0), νˆ(0), ε)
8: Initialize: l(0) ← `(Ψˆ(0), νˆ(0))
9: for t = 1, 2, 3, ... do
10: Ψˆ(t) ← U
(
Ψˆ(t−1), νˆ(t−1)
)
11: νˆ(t) ← arg maxν `
(
Ψˆ(t), ν
)
12: l(t) ← `
(
Ψˆ(t), νˆ(t)
)
13: if l(t) − l(t−1) < ε then
14: return
(
Ψˆ(t), ν(t)
)
15: end if
16: end for
17: end procedure
for Θ(t). We denote the inverse of the estimate obtained by repeated iteration
of (2.6) by ΨˆEM. The EM algorithm can be sensitive to starting values.
Hence, starting the algorithm in different starting values can help assesing
if a global maximum has been reached.
An approximate maximum likelihood estimator using a first order approx-
imation is also possible (derived in Appendix E).
2.4. Estimation procedure. We propose a procedure alternating between
estimating ν and Ψ while keeping the other fixed. Given parameters νˆ(t)
and Ψˆ(t) at iteration t, we estimate Ψˆ(t+1) using fixed νˆ(t). Subsequently, we
find νˆ(t+1) by a standard one-dimensional numerical optimization procedure
using the fixed Ψˆ(t+1). This coordinate ascent approach is repeated until
convergence as described in Algorithm 1. The update function U in the
algorithm is defined by the derived estimators. That is, equations (2.4),
(2.6), or (E.2) define U as the pooled, EM, or approximate MLE estimates,
respectively.
The procedure using the EM step utilizes the results about the RCM
log-likelihood and thus provides a guarantee of convergence along with the
advantage of a very simple implementation. Both the EM step and the ν up-
date will always yield an increase in the likelihood. The disadvantage is that
the identified stationary point might be a local maximum or saddle-point
when considering the log-likelihood function jointly in (Ψ, ν). Intuitively, the
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latter possibility happens with zero probability, but it cannot be excluded
that the maximum found is not global.
Variations on the convergence criterion can also be considered, such as (a)
using the difference in successive parameter estimates, or (b) using relative
rather than absolute differences.
2.5. Interpretation and inference.
Intra-study correlation coefficient. The heterogeneity parameter ν has
no straightforward interpretation partly because the values of ν which cor-
responds to a large study heterogeneity is dependent on the dimension p.
We therefore introduce a descriptive statistic analogous to the intra-study
correlation coefficient (ICC) (Shrout and Fleiss, 1979) well known from or-
dinary meta-analysis. For the RCM this follows from the definition of the
ICC which is defined to be the ratio of the between-study variation Var(Σij)
and the total variation Var(Sij) of any single pair of variables. In Appendix
F it is shown that the ICC is given by:
ICC(ν) =
1
ν − p.(2.7)
The ICC might in this sense be utilized in better quantifying the repro-
ducibility of the covariance across studies. A straight-forward plug-in esti-
mator ÎCC(ν) of the ICC of some gene-gene interaction is then ICC(νˆ).
Though v > p + 3 is required for the variances to exist, it is clear that
ICC(ν) → 1 for ν → (p + 1)+ and ICC(ν) → 0 for ν → ∞ as should be
expected.
Test for no study heterogeneity. By the RCM ν parameterizes an inter-
study variance where the size of ν corresponds to the homogeneity between
the studies. A large ν yields high study homogeneity while a small ν yields
low homogeneity. Thus, it might be of interest to test if the estimated ho-
mogeneity νˆ is extreme under the null-hypothesis of no heterogeneity (i.e.
infinite homogeneity). I.e. a test for the hypothesis H0 : ν = ∞ which is
equivalent to
H0 : Σ1 = ... = Σk = Σ.
The two are equivalent since sampling the covariance matrix from the in-
verse Wishart distribution becomes deterministic for ν = ∞. Therefore,
testing this hypothesis can also be interpreted as testing whether the data
is adequately explained when leaving out the hierarchical structure.
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The distribution of νˆ under the null hypothesis is not tractable. However,
in practice under H0 or when ν is extremely large the estimated νˆobs will be
finite as the intra-study variance dominates the total variance. We note that
the null distribution of νˆ does not depend on Σ. We propose approximating
the distribution of νˆ under H0 by resampling. To do this, the model is
simply fitted a large number of times N on datasets re-sampled under H0
mimicked by permuted study labels to get νˆ
(1)
0 , ..., νˆ
(N)
0 . As small values of νˆ
are critical for H0 approximate acceptance regions can be constructed from
νˆ
(j)
0 , j = 1, ..., N . Likewise, an approximation of the p value testing H0 can
be obtained by
P =
1
N + 1
(
1 +
N∑
j=1
1
[
νˆ
(j)
0 < νˆobs
])
,(2.8)
where 1[ · ] is the indicator function. The addition of one to both nominator
and denominator adds a positive bias to the approximate p-value and is
considered minimally needed according to Phipson and Smyth (2010). This
is approximately the fraction of νˆ
(j)
0 ’s smaller than νˆobs.
2.6. Implementation and availability. Algorithm 1 and the different esti-
mators are implemented in the statistical programming language R (R Core
Team, 2012) with core functions in C++ using packages Rcpp and RcppAr-
madillo (Eddelbuettel and Franc¸ois, 2011; Franc¸ois, Eddelbuettel and Bates,
2012). They are incorporated in the open-source R-package correlateR
freely available for forking and editing (Bilgrau, 2014). We refer to the infor-
mation here for further details and installation instructions. This document
was prepared with knitr (Xie, 2013) and LaTeX. To reproduce this docu-
ment see http://github.com/AEBilgrau/RCM.
3. Simulation experiments.
3.1. Evalutation of Network Estimation. To assess the estimation proce-
dures ability to estimate Σ we generated data from the hierarchical model
(2.1) in two different scenarios. In the first scenario we define a simple block
matrix of dimension p = 40 with four blocks of size 10. Each block has
an internal pairwise correlation of 0.5, blocks 1 and 2 and 3 and 4 have
a correlation of 0.3 between all pairs, and the remaing correlations are set
at 0.1. In the second scenario we select the top 100 genes, ranked by vari-
ance, from the IDRC dataset (see Table 2) and used the scatter matrix of
these genes, scaled as a correlation matrix, as the Σ matrix for simulation.
For both scenarios we performed agglomerative hierchacical clustering using
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Ward-linkage and 1 minus the absolute correlation as a distance measure.
Heatmaps with associated hierarchical clustering of both Σ matrices are
shown in Supplementary Figure A.1.
For both scenarios we simulate data with k = 3 and a range of values
for ni and ν. Each simulation was repeated 100 times, and the correlation
matrix was estimated using the EM, MLE, and Pool approaches as out-
lined in Section 2. The similarity of the estimated and true Σ matrices and
associated networks were evaluated using respectively the Kullback-Leibler
divergence (Mattiussi et al., 2011) and the cophenetic correlation (Sokal
and Rohlf, 1962). The cophenetic correlation is defined as the correlation of
cophenetic distances of all pairwise distances in a tree, where the cophenetic
distance is the height of the lowest point on the tree where two points merge.
Results from the first scenario (EM and Pool method in Table 1, full results
in Supplementary Table A.1) show that for heterogenous data (ν = 50, 100)
and ni ≥ p the EM estimator outperforms the Pool and MLE estimators us-
ing both measures. Examples of tanglegrams comparing networks estimated
with the EM and Pool method and the true Σ matrix are shown in Sup-
plementary Figure A.2. Tanglegrams were constructed using the R-package
dendextend (Galili, 2015). Increasing the ν parameter, thereby making the
data more homogeneous across groups diminishes the advantage of the EM
estimator. Similar results were found in the second scenario using a Σ ma-
trix based on the IDRC dataset (Table A.2). Results furthermore showed
that the estimates in terms of cophenetic correlation for the MLE and Pool
approaches are nearly identical. We expect this to be caused by the fact that
the MLE method is initilized with the Pool estimates and stops after few
iterations; presumably a better estimate cannot be found in these simple
scenarios.
3.2. Computation time for the RCM model. Next we tested the perfor-
mance of the different methods in terms of computation time. Figure 1
shows computation times of the methods with varying values of the dimen-
sion of the data, and demonstrates that the increased performance of the
EM method comes at an extra cost in computation time.
3.3. Evaluation of the hypothesis testing. Finally we investigate the per-
formance of the P-value for the hypothesis test suggested in (2.8). To do
this, we simulate from the hierarchical model with k = 3 and a range of
different values for p, ν, and ni. For these simulations we used a Ψ matrix
with a diagonal of ones and 0.5 for off-diagonal values. Simulations were
done 100 times for each scenario, and 500 permutations were done for each
simulation. Results summarized as boxplots of the P-values obtained in the
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Table 1
Mean cophenetic correlation and Kullback-Leibler divergence with 95% confidence, for
estimated vs true network for different values of ν and ni using the EM or Pool method
Cophenetic Correlation Kullback-Leibler divergence
ni ν EM Pool EM Pool
20 50 0.19 (0.17;0.21) 0.2 (0.18;0.22) 240.37 (232.79;247.94) 227.33 (220.13;234.52)
30 50 0.26 (0.23;0.28) 0.25 (0.23;0.28) 126.61 (123.81;129.41) 121.81 (119.1;124.51)
50 50 0.6 (0.56;0.64) 0.43 (0.39;0.46) 75.62 (73.5;77.74) 73.62 (71.54;75.69)
100 50 0.88 (0.85;0.9) 0.7 (0.67;0.74) 33.04 (32.56;33.52) 30.9 (30.44;31.36)
500 50 0.99 (0.98;0.99) 0.91 (0.89;0.93) 23.64 (23.41;23.88) 21.31 (21.1;21.53)
1000 50 0.99 (0.99;0.99) 0.9 (0.88;0.92) 22.86 (22.59;23.14) 20.53 (20.28;20.78)
20 100 0.35 (0.32;0.38) 0.35 (0.32;0.37) 76.69 (74.05;79.33) 72.36 (69.85;74.86)
30 100 0.4 (0.37;0.42) 0.39 (0.37;0.42) 34.51 (33.76;35.26) 33.14 (32.42;33.87)
50 100 0.72 (0.68;0.75) 0.69 (0.66;0.72) 27.92 (27.2;28.65) 27.26 (26.55;27.97)
100 100 0.97 (0.96;0.98) 0.96 (0.95;0.97) 8.02 (7.88;8.16) 7.85 (7.71;7.98)
500 100 1 (0.99;1) 1 (1;1) 3.34 (3.31;3.38) 3.18 (3.15;3.21)
1000 100 1 (1;1) 1 (1;1) 2.95 (2.92;2.98) 2.79 (2.77;2.82)
20 1000 0.51 (0.48;0.54) 0.51 (0.48;0.54) 52.66 (51.04;54.29) 49.61 (48.07;51.16)
30 1000 0.61 (0.58;0.64) 0.61 (0.58;0.64) 22.5 (22.05;22.95) 21.59 (21.16;22.02)
50 1000 0.81 (0.78;0.84) 0.81 (0.78;0.84) 20.49 (19.91;21.08) 20.02 (19.44;20.59)
100 1000 0.99 (0.98;0.99) 0.99 (0.99;0.99) 4.47 (4.36;4.58) 4.42 (4.31;4.52)
500 1000 1 (1;1) 1 (1;1) 0.71 (0.7;0.72) 0.71 (0.7;0.72)
1000 1000 1 (1;1) 1 (1;1) 0.41 (0.41;0.42) 0.41 (0.4;0.42)
20 10000 0.53 (0.5;0.55) 0.52 (0.5;0.55) 53.15 (51.26;55.04) 50.07 (48.28;51.86)
30 10000 0.65 (0.61;0.68) 0.64 (0.61;0.68) 21.91 (21.46;22.35) 21.01 (20.59;21.44)
50 10000 0.83 (0.8;0.85) 0.82 (0.79;0.85) 19.88 (19.29;20.48) 19.42 (18.84;20.01)
100 10000 0.99 (0.99;1) 0.99 (0.99;1) 4.19 (4.11;4.27) 4.14 (4.06;4.22)
500 10000 1 (1;1) 1 (1;1) 0.59 (0.58;0.6) 0.59 (0.58;0.6)
1000 10000 1 (1;1) 1 (1;1) 0.28 (0.27;0.28) 0.28 (0.27;0.28)
Fig 1: The mean computation time of 10 fits with varying dimension p.
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100 simulations for each scenario are shown in Supplementary Figure A.3.
We find that for heterogenous data (e.g. p = 20, ν = 30) the null-hypothesis
is clearly rejected if ni > p. When increasing ν thus making the groups more
similar, more observations are needed to reject the null hypothesis, while for
identical groups, i.e. ν = ∞, the null-hypothesis is generally not rejected.
The P-values obtained from the permuation test thus performs as intended.
4. DLBCL meta-analysis. Diffuse large B-cell lymphoma (DLBCL)
is an aggressive cancer subtype accounting for 30%− 58% of non-Hodgkin’s
lymphomas (NHL) which constitutes about 90% of all lymphomas (Interna-
tional Lymphoma Study Group, 1997).
4.1. Data and preprocessing. A large amount of DLBCL gene expres-
sion datasets are now available online at the NCBI (National Center for
Biotechnology Information) Gene Expression Omnibus (GEO) website. Ten
large-scale DLBCL gene expression studies were downloaded and prepro-
cessed using custom brainarray chip definition files (CDF) (Dai et al., 2005)
and RMA-normalized using the R-package affy (Gautier et al., 2004). The
corresponding GEO-accession numbers and microarray platforms used are
seen in Table 2. The downloaded data yield a total of 2046 samples with
study sizes in the range 78-469. The summarization using brainarray CDFs
to Ensembl gene identifiers facilitates cross-platform integration.
After RMA normalization and summarization, the data were brought to
a common scale by quantile normalizing all data to the common cumulative
distribution function of all arrays. Lastly, the datasets were reduced to 11573
common genes represented in all studies and array platforms. Figure A.4
shows a plot of the first and second principal components of the combined
dataset. We see a clear split on the first principal component, indicitating
a possible batch effect and heterogeneous data, and thus a situation where
the EM estimator might offer an advantage compared to the simpler Pool
approach.
4.2. Analysis. For each dataset the scatter matrix Si of the top 300 most
variable genes (as measured by the pooled variance across all studies) was
computed as the sufficient statistics along with the number of samples.
The parameters of the RCM were estimated using the EM algorithm
and yielded the 300 × 300 matrix Ψˆ, νˆ = 773.16, and ICC = 0.0021. The
RCM was fitted using three different initial sets of parameters which all
converged to the same parameter estimates. Log-likelihood traces, iterations
used, and computation times are seen in Figure 2. From the parameter
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Table 2
Overview of studies used with GEO accession number from the NCBI Gene expression
omnibus website, the relevant reference, array types used in the study, and number of
samples and features on the used array.
GEO no. Name Reference Used arrays n
1 GSE56315 CHEPRETRO Dybkær et al. (2015) hgu133plus2 89
2 GSE19246 BCCA Williams et al. (2010) hgu133plus2 177
3 GSE12195 CUICG Compagno et al. (2009) hgu133plus2 136
4 GSE22895 HMRC Jima et al. (2010) hugene10st 101
5 GSE31312 IDRC Visco et al. (2012) hgu133plus2 469
6 GSE10846 LLMPP R-CHOP Lenz et al. (2008) hgu133plus2 181
7 GSE10846 LLMPP CHOP Lenz et al. (2008) hgu133plus2 233
8 GSE34171 MDFCI Monti et al. (2012) hgu133plus2,
snp6
90
9 GSE34171 MDFCI Monti et al. (2012) hgu133a,
hgu133b
78
10 GSE22470 MMML Salaverria et al. (2011) hgu133a 271
11 GSE4475 UBCBF Hummel et al. (2006) hgu133a 221
estimate, the common expected covariance Σˆ = (νˆ−p−1)−1Ψˆ was computed
and subsequently scaled to the corresponding correlation matrix Rˆ.
Despite the low ICC value the permutation test yielded a P-value for
the null hypothesis of study homogeneity of 0.002, clearly rejecting it. This
means a significant difference has been detected between the estimated co-
variance structures across studies. This low ICC might suggest selecting the
most variable genes bias the ICC towards inter-study homogeneity of co-
variances. To further investigate the low ICC value we randomly sampled
300 genes and estimated the ν parameter 100 times. This gave a value of
ν ranging from 382.69 to 395.18 with a mean of 388.87, corresponding to
an ICC ranging from 0.0105 to 0.0121 with a mean of 0.0113; histograms
are shown in Supplementary Figure A.7. This indicates a bias towards more
homogeneity for the high variance selected genes.
For simplicity we employed a standard network analysis to the estimated
common correlation matrix Rˆ across all studies. To identify clusters with
high internal correlation, we used agglomerative hierarchical clustering with
Ward-linkage and distance measure defined as 1 minus the absolute value of
the correlation. The dendrogram was arbitrarily pruned at a height which
produced 5 modules. The Modules are given different colors. Figure 3 shows
the heatmap, associated network modules and suggested function.
We checked if the identified modules were prognostic for overall survival
(OS) in the CHOP and R-CHOP-treated cohort datasets of GSE10846. To
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Fig 2: The trace of the log-likelihood for three different starting values of
Ψ and ν using the EM algorithm and computational times in minutes. The
number of iterations used for each fit is shown above.
Fig 3: Heatmap and correlation network for the estimated correlation ma-
trices of the top 300 genes for the DLBCL data using the EM method. The
network is cut at a height producing 5 clusters
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Fig 4: The top row shows 95% and 99% CI for the hazard ratio for each
eigengene in the multiple Cox proportional hazards model containing all
eigengenes in the CHOP and R-CHOP dataset. The bottom row shows
Kaplan-Meier estimates (and 95% CI) for the overall survival for patients
stratified by the dichotomized olivegreen eigengene.
do this, the eigengene (Horvath, 2011) for each module was computed. The
module eigengene is the first principal component of the expression matrix
of the module which thus can be represented by a linear combination of the
module genes. We also report the amount of variation the eigengene repre-
sents by calculating the explained variation of the first pricipal component.
Multiple Cox proportional hazards model for OS was fitted with the mod-
ule eigengenes as covariates. For the prognostically interesting and tightly
clustered olivegreen module, the Kaplan-Meier estimates were computed for
groups arising when dichotomizing the values of the corresponding eigen-
gene as above or below the median value. These results are shown in Figure
4. The proportion of variance explained by the eigengene in the CHOP and
R-CHOP datasets for respectively the Coral, Olivegreen, Gray, Skyblue and
Orchid modules were 0.72, 0.6, 0.11, 0.7, 0.31, and 0.77, 0.55, 0.11, 0.7, 0.31.
Next, the modules were screened for biological relevance using GO (Gene
Ontology) Biological Process, Molecular Function, and Cellular Component
as well as REACTOME and KEGG pathway enrichment analysis. This was
done using the g:profiler web server (Reimand et al., 2016) via the accom-
panying R-package gProfileR (Reimand, Kolde and Arak, 2016). Since we
pre-selected the top 300 genes by variance, the enrichment analysis was
done using only these as the background genes. Top genes for each module,
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Gray Olivegreen Orchid Skyblue Coral
n = 159 n = 50 n = 50 n = 31 n = 10
MYBL1 FCER1G CD2 COL5A2 KRT6A
BATF C1QB CD3D COL1A2 SPRR1A
STAP1 C1QA GIMAP4 COL3A1 SPRR1B
CYB5R2 GBP1 PTGDS THBS2 KRT13
TNFRSF13B RARRES3 CCL19 COL6A3 SPRR3
CD44 IDO1 CLU COL1A1 S100A2
MARCKSL1 CD14 ADAMDEC1 COL5A1 KRT14
LRMP LILRB2 TRBC2 VCAN DSP
HCK SERPING1 ITM2A FAP KRT5
MME PSTPIP2 LGALS2 MMP2
LMO2 GZMA ITK SULF1
VPREB3 CCL8 PLA2G2D MXRA5
BCL2A1 IFNG IL7R DCN
BLNK GBP2 PLA2G7 LUM
HLA-DOB CXCL10 ENPP2 SPARC
RRAS2 SLAMF7 IL18 POSTN
STAG3 FGL2 CHI3L1 COL15A1
BACH2 CD163 TFEC TMEM45A
CCND2 CXCL11 CXCL13 COL11A1
PDGFD GZMH CCL21 CTSK
NCF2 ALDH1A1 CSTA EMP1
SPINK2 CXCL9 MMP9 AEBP1
MNDA GZMK LYZ TGFBI
MS4A1 GZMB HSD11B1 GJA1
CD22 KCNJ2 APOC1 PLS3
OSBPL10 CPVL CXCL14 TIMP1
GPR137B IGSF6 C3 ANXA1
GRHPR LGMN MAL TNFAIP6
SORL1 MT2A CYP27B1 SPP1
IGF2BP3 MT1G LAMP3
SYBU CD8A CHIT1
TCL1A MS4A4A PLAC8
ZNF804A CRTAM SELL
SLC12A8 S100A9 KLRB1
CTGF MARCO CD69
FCRL2 S100A8 ROBO1
DUSP5 MT1M ORM1
CCR10 GPX3 S1PR1
ALOX5AP GNLY CCR7
RGCC MT1E GPR183
Table 3
The identified modules, their sizes, and member genes. The genes are sorted decreasingly
by their intra-module connectivity (sum of the incident edge weights). Only the top 40
genes are shown.
ranked by connectivity, are shown in Table 3, while results of the enrich-
ment analysis for each of the modules are shown in Supplementary Table
A.3. Inspection of the enrichment analysis and most connected genes allowed
us to hypothesize that the coral module is involved in ”tissue development”
(strong association with GO:0009888 tissue development), the Skyblue mod-
ule is involved in ”metastasis” (strong association with G0:0009611-response
to wounding and GO.00442060-wound healing, (Arnold et al., 2015)), the
orchid module involved in ”immune regulation” (strong association with
GO:0002376-immune system process), and the olivegreen module involved
in ”immune surveillance” (strong association with GO:0006952-defense re-
sponse and GO:0045087-innate immune response).
From the gene enrichment and survival analysis the olivegreen module ap-
peared particularly interesting, as we notice a strong involvement of immune
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response and an association between high value of the eigengene expression
and poor survival, which eventually could make these patients candidates for
experimental immunotherapies. Several of the genes, e.g. S100A8, S100A9,
CD14, and CD163 with the highest connectivity in this module have been
associated to immunotherapy (Fulmer, 2008; Cheng et al., 2008; Stroncek
et al., 2017). As prominent examples S100A8 (MRP8; calgranulin A) and the
gene S100A9 (MRP14; calgranulin B) appear in the list. This is interesting as
compelling research has shown that the S100 family of calciumbinding pro-
teins maintain immunosuppressive myeloid-derived suppressor (MDS) cells
at the tumor site (Fulmer, 2008). Notably, in mice injected with lymphoma
cells, knockout of S100A9 resulted in greater tumor infiltration of T-cells and
less accumulation of MDS cells than that seen in wild-type mice (Cheng
et al., 2008). The knockout mice had higher rates of tumor rejection and
lower tumor size than their wild-type littermates. This result indicates that
knockdown of these proteins may improve the outcome of immunotherapy
strategies in patients with values of the eigengene of the olivegreen module.
Finally, we compared the network analyses based on the covariance matrix
obtained by the EM to that obtained by the Pool methods. The upper row
of Supplementary Figure A.5 shows the heatmap and associated network
modules for the Pool method, when the dendogram is cut at 5 modules,
Supplementary Figure A.6 shows plots for the survival analysis, and top
genes and gene enrichments are given in Supplementary Tables A.4 and A.5.
For the Pool method, we chose for each module the same color as the module
of the EM based clustering with most overlapping genes. In the lower row of
Figure A.5 a tangleram was constructed and the cophenetic correlation was
calculated. We noticed generally a great overlap between the modules, but a
low cophenetic correlation. With background in the simulation we anticipate
the Pool method has lower efficiency than the EM method.
The olivegreen and coral modules seem to be so tightly regulated that
they manifest themselves for both methods, which is also seen in the enrich-
ment analyses. However, the size of the skyblue module is increased for the
pool method by acquiring genes from the grey module identified by the EM
method, but the overall enrichment is not changed. For the orchid module,
we notice a number of genes ending up in the grey module for the pool
method. This has the consequence that the immune regulation fingerprint
disappers using the pool method. Morever, if we look at the less correlated
intramodular connections the noise plays a larger role leading to a less clear
separation between the modules for the Pool method. This can have po-
tential biological implications, when regulating hub genes resulting in intra
module cascades of reactions.
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5. Discussion. The RCM for meta-analysis of covariance structures
was shown to be superior to simple pooling as suggested previously in the
literature. The estimated covariance matrix was also capable of providing
a dissimilarity measure, which was able to pinpoint alternative biologically
meaningful gene correlation networks in DLBCL, which can be used to for-
mulate new hypothesis about the role of immune therapy in DLBCL.
However, the proposed testing is computationally demanding and only
feasible when p is sufficiently small. This could e.g. be overcome by improved
and faster fitting procedures or by deriving the distribution of νˆ under the
null hypothesis. Yet the latter is seemingly intractable as νˆ is a very complex
function of the data. The fact that the null-hypothesis lies on the edge
of the parameter space also seems to constrain the feasibility of deriving
such a distribution. One might question whether the added utility of the
ν parameter provides sufficient relaxation of the covariance homogeneity.
Therefore, the present work should be considered a first step in the direction
of explicitly modelling the inter-study variation of covariance matrices. It
is also worth noticing, that although the suggested method proved to be
superior to simple pooling, it only works for small or moderate numbers of
features p. This can partly be alleviated by combining multiple studies to
yield a sufficiently large total sample size n• that allows for the estimation
of large covariance matrices. Turning to using p-values seems tempting, but
one should be aware, as with all hypothesis testing, that the exact threshold
of ICC (or ν) needed to claim homogeneous studies is dependent on the
sample size and the relevant effect size. In this respect the relevant effect
size is unclear and will be problem dependent.
The moderate size of p is a severe drawback as many methods have been
published concerning estimation of large covariance matrices by various reg-
ularization methods (Meinshausen and Bu¨hlmann, 2006; Friedman, Hastie
and Tibshirani, 2008; van Wieringen and Peeters, 2016). Therefore we be-
lieve this work could be further enriched by combining the method with
regularized estimation. In the future such generalizations of the model to
p n• is extremely interesting though out of scope for this article.
In conclusion the article demonstrates an advantageous model based way
of conducting meta-analaysis of covariance matrices - especially in a setting
with moderate number of features compared to the dimension. One should
also notice the method seems to provide a generally applicable framework
making it usable in other settings where multiple features are measured and
believed to share a common covariance matrix obscured by group dependent
noise.
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APPENDIX A: SUPPLEMENTARY FIGURES AND TABLES
Fig A.1: Heatmaps and hierarchical clustering of the Σ matrices used for
simulation.
A2 A. BILGRAU ET AL.
Fig A.2: Tanglegrams for the True vs estimated dendrograms with the EM
and Pool method.
Fig A.3: Boxplot of obtained P-values from the permutation procedure under
different values of p, ν and ni.
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Fig A.4: PCA plot of the datasets used in the DLBCL analysis.
A4 A. BILGRAU ET AL.
Fig A.5: Heatmap and correlation network for the estimated correlation
matrices of the top 300 genes for the DLBCL data using the Pool method.
The network is cut at a height producing 5 clusters. The tanglegram in
the lower panel shows the comparison of clusters between the EM and Pool
methods.
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Fig A.6: The top row shows 95% and 99% CI for the hazard ratio for
each eigengene in the multiple Cox proportional hazards model contain-
ing all eigengenes in the CHOP or R-CHOP dataset. The bottom row shows
Kaplan-Meier estimates (and 95% CI) for the overall survival for patients
stratified by the dichotomized olivegreen obtained from the Pool method.
The proportion of variance explained by the eigengene in the CHOP and
R-CHOP datasets for respectively the Coral, Olivegreen, Gray, Skyblue and
Orchid modules were 0.72, 0.62, 0.13, 0.47, 0.33, and 0.77, 0.58, 0.13, 0.48,
0.31
A6 A. BILGRAU ET AL.
Fig A.7: Distribution of ν and the corresponding ICC when fitting the RCM
with the EM method to random subsets of 300 genes.
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Table A.3: The significant terms for the gene enrichment , analysis of the
DLBCL EM method modules. Number of genes , in each term (N), and the
overlap to module (O).
Term ID Domain Term P N O
Gray
GO : 0097159 MF organic cyclic compound bindin 5.55e− 03 157 50
GO : 1901363 MF heterocyclic compound binding 6.64e− 03 157 48
TF : M009401 tf Factor: E2F-1; motif: NTTTCGCG 1.50e− 02 157 34
TF : M006950 tf Factor: ETF; motif: GVGGMGG; m 2.38e− 03 157 78
TF : M004281 tf Factor: E2F-1; motif: NKTSSCGC 1.23e− 03 157 56
TF : M038071 tf Factor: SP2; motif: GNNGGGGGCG 4.27e− 02 157 40
TF : M011990 tf Factor: RNF96; motif: BCCCGCRG 3.63e− 02 157 65
TF : M011991 tf Factor: RNF96; motif: BCCCGCRG 4.27e− 02 157 40
TF : M048690 tf Factor: Egr-1; motif: GCGCATGC 2.42e− 02 157 99
TF : M048691 tf Factor: Egr-1; motif: GCGCATGC 1.87e− 03 157 88
TF : M072501 tf Factor: E2F-1; motif: NNNSSCGC 3.95e− 02 157 54
TF : M088741 tf Factor: E2F1; motif: NNNNNGCGS 1.61e− 02 157 36
TF : M008031 tf Factor: E2F; motif: GGCGSG; ma 3.88e− 04 157 87
TF : M009381 tf Factor: E2F-1; motif: TTGGCGCG 5.69e− 03 157 40
TF : M020900 tf Factor: E2F-4; motif: GCGGGAAA 1.38e− 02 157 117
Olivegreen
GO : 0006952 BP defense response 7.88e− 04 48 29
GO : 0045087 BP innate immune response 3.99e− 04 48 20
GO : 0045088 BP regulation of innate immune re 2.33e− 02 48 10
GO : 0009615 BP response to virus 4.94e− 02 48 9
GO : 0009607 BP response to biotic stimulus 2.64e− 02 48 18
REAC : 5660526 rea Response to metal ions 5.00e− 02 48 4
REAC : 5661231 rea Metallothioneins bind metals 5.00e− 02 48 4
Orchid
GO : 0002376 BP immune system process 2.90e− 02 49 36
GO : 0006644 BP phospholipid metabolic process 1.83e− 02 49 8
REAC : 2730905 rea Role of LAT2/NTAL/LAB on calci 1.08e− 02 49 5
REAC : 2029482 rea Regulation of actin dynamics f 4.98e− 02 49 4
REAC : 2029485 rea Role of phospholipids in phago 4.98e− 02 49 4
REAC : 2871809 rea FCERI mediated Ca+2 mobilizati 1.08e− 02 49 5
REAC : 2871837 rea FCERI mediated NF-kB activatio 4.98e− 02 49 4
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Table A.3: (continued)
Term ID Domain Term P N O
Skyblue
GO : 0009719 BP response to endogenous stimulu 8.88e− 03 31 12
GO : 0009611 BP response to wounding 4.05e− 03 31 12
GO : 0042060 BP wound healing 9.50e− 03 31 11
GO : 0071230 BP cellular response to amino aci 2.58e− 02 31 5
GO : 0032502 BP developmental process 1.34e− 02 31 26
GO : 0048856 BP anatomical structure developme 2.78e− 03 31 26
GO : 0009888 BP tissue development 1.16e− 02 31 16
GO : 0009653 BP anatomical structure morphogen 2.64e− 03 31 18
GO : 0051093 BP negative regulation of develop 1.07e− 03 31 12
GO : 0048646 BP anatomical structure formation 3.52e− 02 31 12
GO : 0044767 BP single-organism developmental 9.58e− 03 31 26
GO : 0007275 BP multicellular organism develop 4.02e− 04 31 26
GO : 0048731 BP system development 2.28e− 03 31 24
GO : 0072359 BP circulatory system development 1.83e− 04 31 14
GO : 0001501 BP skeletal system development 8.37e− 09 31 15
GO : 0072358 BP cardiovascular system developm 2.66e− 03 31 12
GO : 0001944 BP vasculature development 2.66e− 03 31 12
GO : 0001568 BP blood vessel development 2.66e− 03 31 12
GO : 0010243 BP response to organonitrogen com 3.02e− 02 31 9
GO : 0032501 BP multicellular organismal proce 2.06e− 02 31 28
GO : 0071840 BP cellular component organizatio 1.36e− 03 31 25
GO : 0016043 BP cellular component organizatio 1.11e− 03 31 25
GO : 0043062 BP extracellular structure organi 1.77e− 13 31 20
GO : 0030198 BP extracellular matrix organizat 1.77e− 13 31 20
GO : 0030199 BP collagen fibril organization 1.13e− 03 31 7
GO : 0050953 BP sensory perception of light st 4.98e− 02 31 4
GO : 0007601 BP visual perception 4.98e− 02 31 4
GO : 0009056 BP catabolic process 6.84e− 03 31 16
GO : 0044712 BP single-organism catabolic proc 1.14e− 04 31 14
GO : 0044236 BP multicellular organism metabol 2.82e− 05 31 11
GO : 0044243 BP multicellular organismal catab 1.48e− 06 31 11
GO : 0044259 BP multicellular organismal macro 2.82e− 05 31 11
GO : 0032963 BP collagen metabolic process 2.82e− 05 31 11
GO : 0030574 BP collagen catabolic process 1.48e− 06 31 11
GO : 0012505 CC endomembrane system 1.91e− 03 31 23
GO : 0005576 CC extracellular region 2.40e− 03 31 28
GO : 0099080 CC supramolecular complex 2.43e− 03 31 11
GO : 0099081 CC supramolecular polymer 2.43e− 03 31 11
GO : 0099512 CC supramolecular fiber 2.43e− 03 31 11
GO : 0044421 CC extracellular region part 1.18e− 04 31 28
GO : 0005615 CC extracellular space 9.33e− 06 31 25
GO : 0031012 CC extracellular matrix 4.04e− 10 31 19
GO : 0044420 CC extracellular matrix component 6.83e− 12 31 13
GO : 0005578 CC proteinaceous extracellular ma 3.49e− 11 31 18
GO : 0005604 CC basement membrane 3.66e− 05 31 7
GO : 0043234 CC protein complex 2.49e− 03 31 13
GO : 0005581 CC collagen trimer 4.24e− 07 31 11
GO : 0098644 CC complex of collagen trimers 3.66e− 05 31 7
GO : 0098643 CC banded collagen fibril 3.66e− 05 31 7
GO : 0005583 CC fibrillar collagen trimer 3.66e− 05 31 7
GO : 0044432 CC endoplasmic reticulum part 8.73e− 03 31 10
GO : 0005788 CC endoplasmic reticulum lumen 2.57e− 05 31 8
GO : 0050840 MF extracellular matrix binding 2.58e− 02 31 5
GO : 0048407 MF platelet-derived growth factor 4.98e− 02 31 4
GO : 0043169 MF cation binding 1.18e− 03 31 18
GO : 0046872 MF metal ion binding 4.93e− 04 31 18
GO : 0005201 MF extracellular matrix structura 1.18e− 05 31 9
GO : 0044877 MF macromolecular complex binding 3.26e− 02 31 10
GO : 0032403 MF protein complex binding 2.16e− 02 31 10
HP : 0000002 hp Abnormality of body height 4.37e− 02 31 12
KEGG : 04510 keg Focal adhesion 4.99e− 02 31 5
KEGG : 04974 keg Protein digestion and absorpti 4.45e− 04 31 8
KEGG : 04512 keg ECM-receptor interaction 1.65e− 02 31 5
REAC : 3781865 rea Diseases of glycosylation 7.07e− 03 31 4
REAC : 1474244 rea Extracellular matrix organizat 6.26e− 11 31 17
REAC : 3000178 rea ECM proteoglycans 7.07e− 03 31 4
REAC : 1474228 rea Degradation of the extracellul 3.07e− 02 31 6
REAC : 1474290 rea Collagen formation 2.98e− 05 31 9
REAC : 2022090 rea Assembly of collagen fibrils a 1.97e− 04 31 8
REAC : 1650814 rea Collagen biosynthesis and modi 1.85e− 07 31 9
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Table A.3: (continued)
Term ID Domain Term P N O
Coral
GO : 0009888 BP tissue development 1.02e− 03 10 9
GO : 0060429 BP epithelium development 7.35e− 07 10 9
GO : 0030855 BP epithelial cell differentiatio 1.01e− 08 10 9
GO : 0008544 BP epidermis development 2.23e− 10 10 9
GO : 0009913 BP epidermal cell differentiation 2.47e− 11 10 9
GO : 0008219 BP cell death 3.95e− 03 10 9
GO : 0012501 BP programmed cell death 2.22e− 03 10 9
GO : 0043588 BP skin development 5.35e− 09 10 9
GO : 0030216 BP keratinocyte differentiation 2.47e− 11 10 9
GO : 0031424 BP keratinization 1.13e− 12 10 9
GO : 0070268 BP cornification 1.44e− 10 10 8
GO : 0018149 BP peptide cross-linking 3.55e− 02 10 4
GO : 0099513 CC polymeric cytoskeletal fiber 4.54e− 03 10 5
GO : 0045111 CC intermediate filament cytoskel 3.76e− 05 10 5
GO : 0005882 CC intermediate filament 6.36e− 06 10 5
GO : 0045095 CC keratin filament 3.06e− 04 10 4
GO : 0001533 CC cornified envelope 4.44e− 03 10 4
GO : 0005198 MF structural molecule activity 4.41e− 05 10 8
GO : 0005200 MF structural constituent of cyto 2.00e− 02 10 4
HPA : 05303001 hpa tonsil; squamous epithelial ce 9.03e− 03 10 9
HPA : 05303002 hpa tonsil; squamous epithelial ce 1.63e− 04 10 9
HPA : 05303011 hpa tonsil; squamous epithelial ce 7.87e− 05 10 9
HPA : 05303012 hpa tonsil; squamous epithelial ce 2.70e− 06 10 9
HPA : 02901001 hpa oral mucosa; squamous epitheli 2.59e− 03 10 9
HPA : 02901002 hpa oral mucosa; squamous epitheli 8.70e− 04 10 8
HPA : 02901003 hpa oral mucosa; squamous epitheli 9.38e− 03 10 5
HPA : 02901011 hpa oral mucosa; squamous epitheli 3.54e− 05 10 9
HPA : 02901012 hpa oral mucosa; squamous epitheli 8.81e− 05 10 8
HPA : 02901013 hpa oral mucosa; squamous epitheli 9.38e− 03 10 5
HPA : 01501001 hpa esophagus; squamous epithelial 3.06e− 03 10 9
HPA : 01501002 hpa esophagus; squamous epithelial 1.29e− 04 10 9
HPA : 01501003 hpa esophagus; squamous epithelial 9.55e− 05 10 7
HPA : 01501011 hpa esophagus; squamous epithelial 4.66e− 05 10 9
HPA : 01501012 hpa esophagus; squamous epithelial 1.84e− 06 10 9
HPA : 01501013 hpa esophagus; squamous epithelial 3.52e− 05 10 7
HPA : 00902001 hpa cervix, uterine; squamous epit 1.46e− 02 10 8
HPA : 00902002 hpa cervix, uterine; squamous epit 3.99e− 04 10 8
HPA : 00902003 hpa cervix, uterine; squamous epit 1.30e− 03 10 6
HPA : 00902011 hpa cervix, uterine; squamous epit 3.02e− 04 10 8
HPA : 00902012 hpa cervix, uterine; squamous epit 1.33e− 05 10 8
HPA : 00902013 hpa cervix, uterine; squamous epit 8.27e− 04 10 6
HPA : 04203011 hpa skin 1; keratinocytes[Supporte 1.62e− 02 10 7
HPA : 04203012 hpa skin 1; keratinocytes[Supporte 8.13e− 03 10 6
HPA : 05501001 hpa vagina; squamous epithelial ce 1.07e− 03 10 9
HPA : 05501002 hpa vagina; squamous epithelial ce 1.47e− 05 10 9
HPA : 05501003 hpa vagina; squamous epithelial ce 3.00e− 02 10 5
HPA : 05501011 hpa vagina; squamous epithelial ce 7.76e− 06 10 9
HPA : 05501012 hpa vagina; squamous epithelial ce 1.99e− 07 10 9
HPA : 05501013 hpa vagina; squamous epithelial ce 2.11e− 02 10 5
HPA : 04301003 hpa skin 2; epidermal cells[Uncert 9.38e− 03 10 5
HPA : 04301011 hpa skin 2; epidermal cells[Suppor 2.19e− 03 10 8
HPA : 04301012 hpa skin 2; epidermal cells[Suppor 1.46e− 02 10 6
HPA : 04301013 hpa skin 2; epidermal cells[Suppor 9.38e− 03 10 5
OMIM : 131800 omi EPIDERMOLYSIS BULLOSA SIMPLEX, 5.00e− 02 10 2
OMIM : 601001 omi EPIDERMOLYSIS BULLOSA SIMPLEX, 5.00e− 02 10 2
OMIM : 131760 omi EPIDERMOLYSIS BULLOSA SIMPLEX, 5.00e− 02 10 2
OMIM : 131900 omi EPIDERMOLYSIS BULLOSA SIMPLEX, 5.00e− 02 10 2
REAC : 1266738 rea Developmental Biology 8.62e− 07 10 8
TF : M070511 tf Factor: NF-1B; motif: CTGGCASG 6.22e− 03 10 7
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Table A.5: (continued)
Term ID Domain Term P N O
Table A.5: The significant terms for the gene enrichment , analysis of the
DLBCL Pool method modules. Number of genes , in each term (N), and the
overlap to module (O).
Term ID Domain Term P N O
Gray
TF : M009401 tf Factor: E2F-1; motif: NTTTCGCG 3.04e− 02 136 31
Olivegreen
GO : 0006952 BP defense response 2.10e− 03 45 27
GO : 0045087 BP innate immune response 5.53e− 04 45 19
GO : 0045088 BP regulation of innate immune re 9.89e− 03 45 10
REAC : 5660526 rea Response to metal ions 4.98e− 02 45 4
REAC : 5661231 rea Metallothioneins bind metals 4.98e− 02 45 4
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Table A.5: (continued)
Term ID Domain Term P N O
Skyblue
GO : 0051093 BP negative regulation of develop 2.67e− 02 56 14
GO : 0007167 BP enzyme linked receptor protein 8.80e− 03 56 14
GO : 0007178 BP transmembrane receptor protein 2.54e− 03 56 8
GO : 0007517 BP muscle organ development 4.98e− 02 56 9
GO : 0010243 BP response to organonitrogen com 1.71e− 02 56 12
GO : 0043200 BP response to amino acid 1.32e− 02 56 7
GO : 0032501 BP multicellular organismal proce 2.68e− 02 56 45
GO : 0044707 BP single-multicellular organism 4.07e− 02 56 44
GO : 0001503 BP ossification 4.02e− 03 56 12
GO : 0044712 BP single-organism catabolic proc 2.06e− 03 56 17
GO : 0044236 BP multicellular organism metabol 9.61e− 06 56 14
GO : 0044243 BP multicellular organismal catab 6.82e− 05 56 12
GO : 0044259 BP multicellular organismal macro 9.61e− 06 56 14
GO : 0032963 BP collagen metabolic process 9.61e− 06 56 14
GO : 0030574 BP collagen catabolic process 6.82e− 05 56 12
GO : 0070848 BP response to growth factor 1.28e− 04 56 15
GO : 0071363 BP cellular response to growth fa 5.43e− 04 56 14
GO : 0009653 BP anatomical structure morphogen 8.62e− 03 56 25
GO : 0048646 BP anatomical structure formation 1.54e− 02 56 17
GO : 0072359 BP circulatory system development 8.14e− 05 56 19
GO : 0072358 BP cardiovascular system developm 3.32e− 04 56 17
GO : 0001944 BP vasculature development 3.32e− 04 56 17
GO : 0009887 BP animal organ morphogenesis 2.44e− 03 56 14
GO : 0001568 BP blood vessel development 3.32e− 04 56 17
GO : 0048514 BP blood vessel morphogenesis 4.75e− 03 56 14
GO : 0001525 BP angiogenesis 1.69e− 02 56 13
GO : 0071822 BP protein complex subunit organi 1.17e− 02 56 16
GO : 0071840 BP cellular component organizatio 2.24e− 03 56 38
GO : 0016043 BP cellular component organizatio 1.71e− 03 56 38
GO : 0097435 BP supramolecular fiber organizat 1.28e− 04 56 15
GO : 0043062 BP extracellular structure organi 1.19e− 13 56 25
GO : 0030198 BP extracellular matrix organizat 1.19e− 13 56 25
GO : 0030199 BP collagen fibril organization 5.59e− 05 56 9
GO : 0009888 BP tissue development 3.46e− 02 56 22
GO : 0061448 BP connective tissue development 2.97e− 03 56 11
GO : 0001501 BP skeletal system development 1.84e− 09 56 19
GO : 0051216 BP cartilage development 4.43e− 04 56 10
GO : 0009611 BP response to wounding 6.33e− 04 56 17
GO : 0042060 BP wound healing 4.54e− 03 56 15
GO : 0009719 BP response to endogenous stimulu 4.15e− 05 56 19
GO : 0071495 BP cellular response to endogenou 2.93e− 04 56 15
GO : 0005576 CC extracellular region 2.53e− 04 56 46
GO : 0044421 CC extracellular region part 2.09e− 06 56 46
GO : 0005615 CC extracellular space 1.76e− 06 56 38
GO : 0031012 CC extracellular matrix 8.36e− 11 56 25
GO : 0044420 CC extracellular matrix component 3.76e− 08 56 13
GO : 0005578 CC proteinaceous extracellular ma 5.45e− 12 56 23
GO : 0005604 CC basement membrane 1.94e− 03 56 7
GO : 0005581 CC collagen trimer 3.40e− 04 56 11
GO : 0098644 CC complex of collagen trimers 1.94e− 03 56 7
GO : 0098643 CC banded collagen fibril 1.94e− 03 56 7
GO : 0005583 CC fibrillar collagen trimer 1.94e− 03 56 7
GO : 0012505 CC endomembrane system 1.71e− 02 56 33
GO : 0005788 CC endoplasmic reticulum lumen 2.54e− 03 56 8
GO : 0032403 MF protein complex binding 3.00e− 02 56 13
GO : 0043167 MF ion binding 4.41e− 02 56 32
GO : 0043169 MF cation binding 1.24e− 02 56 24
GO : 0046872 MF metal ion binding 4.34e− 03 56 24
GO : 0005201 MF extracellular matrix structura 8.67e− 05 56 10
GO : 0050840 MF extracellular matrix binding 1.11e− 02 56 6
KEGG : 04933 keg AGE-RAGE signaling pathway in 1.62e− 02 56 6
KEGG : 04974 keg Protein digestion and absorpti 3.86e− 02 56 8
REAC : 1474244 rea Extracellular matrix organizat 7.33e− 07 56 18
REAC : 1474290 rea Collagen formation 6.62e− 03 56 9
REAC : 1650814 rea Collagen biosynthesis and modi 6.07e− 05 56 9
REAC : 2022090 rea Assembly of collagen fibrils a 2.10e− 02 56 8
Orchid
GO : 0042581 CC specific granule 4.55e− 02 48 6
GO : 0035580 CC specific granule lumen 4.55e− 02 48 6
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Table A.5: (continued)
Term ID Domain Term P N O
Coral
GO : 0009888 BP tissue development 1.02e− 03 10 9
GO : 0008544 BP epidermis development 2.23e− 10 10 9
GO : 0060429 BP epithelium development 7.35e− 07 10 9
GO : 0030855 BP epithelial cell differentiatio 1.01e− 08 10 9
GO : 0009913 BP epidermal cell differentiation 2.47e− 11 10 9
GO : 0008219 BP cell death 3.95e− 03 10 9
GO : 0012501 BP programmed cell death 2.22e− 03 10 9
GO : 0043588 BP skin development 5.35e− 09 10 9
GO : 0030216 BP keratinocyte differentiation 2.47e− 11 10 9
GO : 0031424 BP keratinization 1.13e− 12 10 9
GO : 0070268 BP cornification 1.44e− 10 10 8
GO : 0018149 BP peptide cross-linking 3.55e− 02 10 4
GO : 0001533 CC cornified envelope 4.44e− 03 10 4
GO : 0099513 CC polymeric cytoskeletal fiber 4.54e− 03 10 5
GO : 0045111 CC intermediate filament cytoskel 3.76e− 05 10 5
GO : 0005882 CC intermediate filament 6.36e− 06 10 5
GO : 0045095 CC keratin filament 3.06e− 04 10 4
GO : 0005198 MF structural molecule activity 4.41e− 05 10 8
GO : 0005200 MF structural constituent of cyto 2.00e− 02 10 4
HPA : 00902001 hpa cervix, uterine; squamous epit 1.46e− 02 10 8
HPA : 00902002 hpa cervix, uterine; squamous epit 3.99e− 04 10 8
HPA : 00902003 hpa cervix, uterine; squamous epit 1.30e− 03 10 6
HPA : 00902011 hpa cervix, uterine; squamous epit 3.02e− 04 10 8
HPA : 00902012 hpa cervix, uterine; squamous epit 1.33e− 05 10 8
HPA : 00902013 hpa cervix, uterine; squamous epit 8.27e− 04 10 6
HPA : 05303001 hpa tonsil; squamous epithelial ce 9.03e− 03 10 9
HPA : 05303002 hpa tonsil; squamous epithelial ce 1.63e− 04 10 9
HPA : 05303011 hpa tonsil; squamous epithelial ce 7.87e− 05 10 9
HPA : 05303012 hpa tonsil; squamous epithelial ce 2.70e− 06 10 9
HPA : 05501001 hpa vagina; squamous epithelial ce 1.07e− 03 10 9
HPA : 05501002 hpa vagina; squamous epithelial ce 1.47e− 05 10 9
HPA : 05501003 hpa vagina; squamous epithelial ce 3.00e− 02 10 5
HPA : 05501011 hpa vagina; squamous epithelial ce 7.76e− 06 10 9
HPA : 05501012 hpa vagina; squamous epithelial ce 1.99e− 07 10 9
HPA : 05501013 hpa vagina; squamous epithelial ce 2.11e− 02 10 5
HPA : 02901001 hpa oral mucosa; squamous epitheli 2.59e− 03 10 9
HPA : 02901002 hpa oral mucosa; squamous epitheli 8.70e− 04 10 8
HPA : 02901003 hpa oral mucosa; squamous epitheli 9.38e− 03 10 5
HPA : 02901011 hpa oral mucosa; squamous epitheli 3.54e− 05 10 9
HPA : 02901012 hpa oral mucosa; squamous epitheli 8.81e− 05 10 8
HPA : 02901013 hpa oral mucosa; squamous epitheli 9.38e− 03 10 5
HPA : 04301003 hpa skin 2; epidermal cells[Uncert 9.38e− 03 10 5
HPA : 04301011 hpa skin 2; epidermal cells[Suppor 2.19e− 03 10 8
HPA : 04301012 hpa skin 2; epidermal cells[Suppor 1.46e− 02 10 6
HPA : 04301013 hpa skin 2; epidermal cells[Suppor 9.38e− 03 10 5
HPA : 01501001 hpa esophagus; squamous epithelial 3.06e− 03 10 9
HPA : 01501002 hpa esophagus; squamous epithelial 1.29e− 04 10 9
HPA : 01501003 hpa esophagus; squamous epithelial 9.55e− 05 10 7
HPA : 01501011 hpa esophagus; squamous epithelial 4.66e− 05 10 9
HPA : 01501012 hpa esophagus; squamous epithelial 1.84e− 06 10 9
HPA : 01501013 hpa esophagus; squamous epithelial 3.52e− 05 10 7
HPA : 04203011 hpa skin 1; keratinocytes[Supporte 1.62e− 02 10 7
HPA : 04203012 hpa skin 1; keratinocytes[Supporte 8.13e− 03 10 6
OMIM : 601001 omi EPIDERMOLYSIS BULLOSA SIMPLEX, 5.00e− 02 10 2
OMIM : 131760 omi EPIDERMOLYSIS BULLOSA SIMPLEX, 5.00e− 02 10 2
OMIM : 131900 omi EPIDERMOLYSIS BULLOSA SIMPLEX, 5.00e− 02 10 2
OMIM : 131800 omi EPIDERMOLYSIS BULLOSA SIMPLEX, 5.00e− 02 10 2
REAC : 1266738 rea Developmental Biology 8.62e− 07 10 8
TF : M070511 tf Factor: NF-1B; motif: CTGGCASG 6.22e− 03 10 7
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Gray Olivegreen Skyblue Orchid Coral
n = 139 n = 47 n = 56 n = 48 n = 10
MYBL1 FCER1G COL5A2 CD2 KRT6A
BATF C1QB COL1A2 PTGDS SPRR1A
STAP1 IDO1 COL3A1 GIMAP4 SPRR1B
MME GBP1 VCAN ADAMDEC1 SPRR3
CD44 C1QA DCN CD3D S100A2
CYB5R2 CD14 COL6A3 CCL19 KRT13
TNFRSF13B GZMA THBS2 IL18 KRT14
LRMP SERPING1 SPARC TFEC DSP
MARCKSL1 RARRES3 SULF1 ITK KRT5
BCL2A1 CXCL10 MMP2 PLA2G2D
HCK PSTPIP2 MXRA5 APOC1
CCND2 GBP2 LUM CHI3L1
VPREB3 FGL2 CTGF LYZ
LMO2 CXCL11 COL15A1 ENPP2
HLA-DOB CCL8 COL5A1 LGALS2
STAG3 LILRB2 FAP CSTA
PDGFD CXCL9 COL1A1 CXCL13
CCR7 CD163 POSTN ITM2A
BLNK GZMB TMEM45A CLU
SORL1 GZMH EMP1 PLA2G7
MNDA GZMK CTSK IL7R
RRAS2 ALDH1A1 PLS3 TRBC2
SPINK2 IFNG TGFBI HSD11B1
BACH2 SLAMF7 GJA1 MMP9
NCF2 CPVL COL11A1 C3
GPR183 KCNJ2 AEBP1 CXCL14
OSBPL10 CD8A TIMP1 CYP27B1
GRHPR MS4A4A TNFAIP6 CHIT1
DUSP5 MT1G ANXA1 LAMP3
ALOX5AP LGMN TAGLN CCL21
CD22 MT2A FOS ROBO1
MS4A1 IGSF6 CILP MAL
SYBU S100A8 DPT KLRB1
TCL1A CRTAM MGP SQOR
FCMR GNLY SPP1 ORM1
GPR137B S100A9 G0S2 SELENOP
IGHM GPX3 STEAP1 P2RY14
SLC12A8 MT1M MMP1 NPY1R
CD83 PLTP EPS8 ORM2
GMDS MARCO GREM1 TRDC
Table A.4
The identified modules from the Pool method, their sizes, and member genes. The genes
are sorted decreasingly by their intra-module connectivity (sum of the incident edge
weights). Only the top 40 genes are shown.
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APPENDIX B: MARGINALIZATION OF THE COVARIANCE
This section shows the marginalization over Σ in (2.3). Recall the model
(2.1) where Np(µ,Σi) denotes a p-dimensional multivariate Gaussian distri-
bution with mean µ and positive definite (p.d.) covariance matrix Σi with
probability density function (pdf)
f(x|µ,Σi) = (2pi)−
p
2 |Σi|− 12 exp
(
−1
2
(x− µ)>Σ−1i (x− µ)
)
,(B.1)
and where W−1p (Ψ, ν) denotes a p-dimensional inverse Wishart distribution
with ν degrees of freedom, a p.d. p× p scale matrix Ψ, and pdf
f(Σi) =
|Ψ| ν2
2
νp
2 Γp
(
ν
2
) |Σi|− ν+p+12 exp(−1
2
tr
(
ΨΣ−1i
))
, ν > p− 1,(B.2)
where Σi is p.d. and Γp is the multivariate generalization of the gamma
function Γ given by
Γp(t) = pi
1
2(
p
2)
p∏
j=1
Γ
(
t+
1− j
2
)
where Γ(t) =
∫ ∞
0
xt−1e−xdx.(B.3)
For ease of notation we drop the subscript i on Σi, Xi, Si = XiX
>
i , and
ni. By the model assumptions,
f(X|Ψ, ν) =
∫
f(X|Σ)f(Σ|Ψ, ν)dΣ
=
∫  n∏
j=1
(2pi)−
p
2 |Σ|− 12 e− 12 tr(xijx>ijΣ−1)
 ∣∣Ψ∣∣ ν2
2
νp
2 Γp
(
ν
2
) |Σ|− ν+p+12 e− 12 tr(ΨΣ−1) dΣ
= (2pi)−
np
2
∣∣Ψ∣∣ ν2
2
νp
2 Γp
(
ν
2
) ∫ |Σ|−n2 e− 12 tr(SΣ−1)|Σ|− ν+p+12 e− 12 tr(ΨΣ−1) dΣ
=
∣∣Ψ∣∣ ν2
pi
np
2 2
(ν+n)p
2 Γp
(
ν
2
) ∫ |Σ|− (ν+n)+p+12 e− 12 tr
((
Ψ+S
)
Σ−1
)
dΣ.
The integrand can be recognized as a unnormalized inverse Wishart pdf of
the distribution W−1(Ψ + S, ν + n), and so the integral evaluates to the
reciprocal value of the normalizing constant in that density. Thus,
f(X|Ψ, ν) =
∣∣Ψ∣∣ ν2
pi
np
2 2
(ν+n)p
2 Γp
(
ν
2
) 2 (v+n)p2 Γp (ν+n2 )∣∣Ψ + S∣∣ ν+n2 =
∣∣Ψ∣∣ ν2 Γp (ν+n2 )
pi
np
2
∣∣Ψ + S∣∣ ν+n2 Γp(ν2 ) .(B.4)
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Using the matrix determinant lemma and S = X>X, this can be further
simplified to
f(X|Ψ, ν) = Γp
(
ν+n
2
)
pi
np
2
∣∣I +XΨ−1X>∣∣ ν+n2 ∣∣Ψ∣∣n2 Γp(ν2) ,
which can help to speed-up computations.
APPENDIX C: PROOFS
C.1. Non-concavity of the log-likelihood. The likelihood function
is not log-concave in general. This section analyses the (non)-concavity of
the log-likelihood function given in (2.3). More precisely, the following two
propositions are proved.
Proposition 1 (Non-concavity in Ψ). For a fixed ν, the log-likelihood
function (2.3) is not concave in Ψ.
Proposition 2 (Concavity in ν). For a fixed positive definite Ψ, the
log-likelihood function (2.3) is concave in ν.
Proof of Proposition 1. Assume ν is fixed and consider only the terms
involving Ψ in (2.3). We reduce to the one-dimensional case where
`(ψ) =
kν
2
log
(
ψ
)− k∑
i=1
ν + ni
2
log
(
ψ + x2i
)
,
which implies
`′(ψ) =
kν
2
1
ψ
−
k∑
i=1
ν + ni
2
1
ψ + x2i
and `′′(ψ) = −kν
2
1
ψ2
+
k∑
i=1
ν + ni
2
1(
ψ + x2i
)2 .
It is straightforward to show there exists a value for ψ, ni and ν for which
`′′(ψ) > 0. Since the second derivative is not always negative the log-
likelihood ` is not log-concave.
Proof of Proposition 2. Consider the terms involving ν. Clearly, the
mixed terms involving both ν and Ψ are log-linear in ν and hence log-
concave. We thus restrict our attention to the remaining terms not depen-
dent on Ψ. The sum of these terms are concave in ν, since
log Γp
(
ν + ni
2
)
− log Γp
(ν
2
)
= log
Γp
(
ν+ni
2
)
Γp
(
ν
2
) = p∑
j=1
log
Γ
(ν+1−j
2 +
ni
2
)
Γ
(ν+1−j
2
) .
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which can be seen to be concave since ni ≥ 1 for all i and h(x) = log
(Γ(x+a)
Γ(x)
)
is concave for all x > 0 and a > 0. The concavity of h is easily seen by the
fact that h′′(x) = ψ(x+a)−ψ(x) < 0, where ψ(·) is the tri-gamma function.
The tri-gamma function is a well-known monotonically decreasing function.
Hence, the likelihood is log-concave in ν.
C.2. Existence and uniqueness of likelihood maxima. This sec-
tion proves Lemmas 1 and 2 which imply Proposition 3.
Before we state the lemmas, the proposition, and their proofs, we see that
the reparameterisation of the RCM is irrelevant. Consider the log-likelihood
in (2.3) assuming ν fixed. The log-likelihood obey
2`(Ψ) = c+ kν log
∣∣Ψ∣∣− k∑
a=1
(na + ν) log
∣∣Ψ + Sa∣∣.(C.1)
Notice, that this equation also holds in the reparameterization. Here we have
2`(Σ) = c+ kν log
∣∣(ν − p− 1)Σ∣∣− k∑
a=1
(na + ν) log
∣∣(ν − p− 1)Σ + Sa∣∣
= c′ + kν log
∣∣Σ∣∣− k∑
a=1
(na + ν) log
∣∣Σ + (ν − p− 1)−1Sa∣∣.
Since (ν−p−1)−1Sa is only dependent on data (when ν is fixed) we can set
(ν − p− 1)−1Sa := Sa. Without loss of generality we can therefore consider
(C.1) in the following.
Proposition 3 (Existence and uniqueness). The log-likelihood (2.3) has
a unique maximum in Ψ for fixed ν and n• =
∑k
a=1 na ≥ p.
Proof of Proposition 3. We first prove existence of the maximum. Note,
that we may consider ` as a function on a vector space by letting Ψ =
exp(X) where X is a symmetric matrix. By Lemma 1 and the continuity of
`, the set
{
Ψ
∣∣`(Ψ) ≥ `(Ψ∗)} is bounded and closed and thus compact for
any Ψ∗  0. The existence of a maximum follows from the extreme value
theorem by the continuity of `. A stationary point exists due to Rolle’s
theorem and the differentiability of `.
Next, we show the uniqueness of the maximum. Let (ST ) denote the set
of stationary points, which is nonempty. By Lemma 1, `(Ψ) has a finite
upper bound given by the maximum of the log-likelihood in those points.
All gradient curves (that is, solution curves to Ψ˙(t) = ∇`(Ψ(t))) must then
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converge toward exactly one of the stationary points where ` monotonically
increases along each curve. Define for ΨsinST the basin of attraction
As =
{
Ψ0 ∈ S+
∣∣Ψ(0) = Ψ0, lim
t→∞Ψ(t) = Ψs
}
,
The basin of attraction is open if Ψs is a maximum (Khalil, 2002, Lemma
4.1). By Lemma 2, Ψs is always a maximum and hence all As are open
sets in the set of all positive definite matrices S+. This partitions the space
S+ into disjoint, non-empty, open sets. Since S+ is connected, this is only
possible if As = S+ and thus there is only a single basin of attraction and
maximum of `.
Lemma 1. If there exists an eigenvalue λt of Ψt such that λt → 0 or
λt →∞, then `(Ψt)→ −∞ for ν fixed and n• =
∑k
a=1 na ≥ p.
Proof of Lemma 1. Assume the hypothesis of the lemma and consider
the expression given in (C.1) up to the addition of a constant. The likelihood
obey the following two upper bounds. First,
`(Ψt) =
kν
2
log
∣∣Ψt∣∣− k∑
i=1
ν + ni
2
log |Ψt + Si|
≤ kν
2
log |Ψt| −
k∑
i=1
ν + ni
2
log |Ψt| = −n•
2
log |Ψt|
Secondly, let C =
∑k
i=1
ν+ni
2 =
kν
2 +
n•
2 , whereby (C.1) can be expressed as
`(Ψt) =
kν
2
log |Ψt| − C
k∑
i=1
ν + ni
2C
log |Ψt + Si|.
Since log | · | is concave and the above sum is a convex combination, we have
`(Ψt) ≤ kν
2
log |Ψt| − C log
∣∣∣∣∣Ψt +
k∑
i=1
ν + ni
2C
Si
∣∣∣∣∣ .
Hence,
`(Ψt) ≤ min
{
−n•
2
a(t),
kν
2
a(t)− C log |Ψt + S|
}
A20 A. BILGRAU ET AL.
where a(t) = log |Ψt| and S =
∑
i
ν+ni
2C Si. Three cases now exists: 1) If
a(t)→∞, then
`(Ψt) ≤ −n•
2
a(t)→ −∞.
2) If a(t)→ −∞, then
`(Ψt) ≤ kν
2
a(t)− C log |Ψt + S| ≤ kν
2
a(t)− C log |S| → −∞
as the matrix in the second term is almost surely positive definite when
n• =
∑k
i=1 na ≥ p and the log determinant is some constant. 3) If a(t) is
bounded and the largest eigenvalue λmax(Ψt)→∞ (and hence λmin(Ψt)→
−∞), then λmax(Ψt + S) → ∞ and λmin(Ψt + S) is bounded away from
zero. Therefore,
`(Ψt) ≤ kν
2
a(t)− C log |Ψt + S| → −∞,
which completes the proof.
Lemma 2. If n• ≥ p and ν is fixed then the Hessian of the log-likelihood
(2.3) is negative definite in all stationary points.
Proof of Lemma 2. We show the conclusion of the Lemma directly by
differentiation of ` w.r.t. Ψ. To do so, the matrix cookbook by Petersen and
Pedersen (2008) is a useful reference. In particular, see equations (41, p. 8)
and (59, p. 9) and pages 14 and 52–53. We first compute expressions for the
first and second order derivatives.
First order derivatives. From the log-likelihood expression, we com-
pute the first order derivative ∇Ψ2`(Ψ) which is the matrix-valued function
where each entry is given by
∂2`
∂Ψij
= kν tr
(
EijΨ−1
)− k∑
a=1
(ν + na) tr
(
Eij (Ψ + Sa)
−1
)
.(C.2)
and Eij is a matrix with ones at entries (i, j) and (j, i) and zeros elsewhere.
This Eij is introduced as the derivative is not straight-forward because of
the symmetric structure of Ψ. Had Ψ been unstructured, then ∂∂Ψ log |Ψ| =
Ψ−1. However, when Ψ is symmetric we have that ∂∂Ψij log |Ψ| = tr(EijΨ−1)
which is the same as ∂∂Ψ log |Ψ| = 2Ψ−1 − Ψ−1 ◦ I where ◦ denotes the
Hadamard product (Petersen and Pedersen, 2008, eq. (43) and (141)).
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The first order derivative lives in a
(
p+1
2
)
-dimensional vector space with
basis vectors Eij indexed by (i, j), i ≤ j.
Second order derivatives. We proceed with the second order derivative
∇2Ψ2`(Ψ) with entries given by
∂22`
∂Ψkl∂Ψij
= −kν tr
(
EijΨ−1EklΨ−1
)
+
k∑
a=1
(ν + na) tr
(
Eij (Ψ + Sa)
−1Ekl (Ψ + Sa)−1
)
,
obtained by differentiation of (C.2) using ∂∂ΨijΨ
−1 = −Ψ−1EijΨ−1 (Pe-
tersen and Pedersen, 2008, eq. (40)) and the linearity of the trace operator.
The second order derivative is a
(
p+1
2
)×(p+12 )-dimensional matrix indexed
by (i, j) and (k, l), i ≤ j, k ≤ l.
Negative definiteness of stationary points. With the above expres-
sions we now show that the Hessian matrix is negative definite in all sta-
tionary points. Let Y =
∑
(i,j) yijE
ij be an arbitrary symmetric matrix in
the vector space where Y 6= 0. In our vector space we need to show that∑
i≤j,k≤l
Yij
(∇2Ψ2`(Ψ))(i,j),(k,l) Ykl < 0
holds in every stationary point analogous to z>Az =
∑
ij Aijzizj < 0. From
the second derivative, this amounts to showing that in every stationary
point,
−kν tr(YΨ−1YΨ−1)+ k∑
a=1
(ν + na) tr
(
Y (Ψ + Sa)
−1
Y (Ψ + Sa)
−1
)
< 0.
(C.3)
Now, by the positive-definiteness of Ψ, let
Y := Ψ−
1
2YΨ−
1
2 and
Sa := Ψ
− 1
2SaΨ
− 1
2 ,
and thus without loss of generality we can assume that Ψ = I. Hence, the
derivative of the likelihood (C.2) equated to zero, becomes
kνI =
∑
a
(na + ν)(I + Sa)
−1
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which implies (by multiplication by Y on each side) that every stationary
point obey
kν tr(Y 2) =
∑
a
(na + ν) tr
(
Y (I + Sa)
−1Y
)
.(C.4)
We substitute (C.4) into (C.3) to get∑
a
(na + ν) tr
(
Y (I + Sa)
−1Y (I + Sa)−1 − Y (I + Sa)−1Y
)
=
∑
a
(na + ν) tr
(
Y (I + Sa)
−1Y
[
(I + Sa)
−1 − I]) < 0.
We note that Sa = XaX
>
a and
(I + Sa)
−1 − I = −Xa
(
I +X>aXa
)−1
X>a ,
by the matrix inversion lemma whereby we need to show that∑
a
(na + ν) tr
(
Y (I +XaX
>
a )
−1Y Xa
(
I +X>aXa
)−1
X>a
)
> 0.
Assume that the sum is actually zero. Since (I + XaX
>
a )
−1  0 we then
obtain that
Y Xa(I +XaX
>
a )
−1X>a Y = 0 for a = 1, ...., k.
Again by (I+XaX
>
a )
−1  0 we conclude that Y Xa = 0 for all a = 1, ..., k,
i.e. Y (X1, ...,Xk) = 0. If n• ≥ p then almost surely (X1, ...,Xk) has rank
p whereby Y = 0.
APPENDIX D: LIKELIHOOD OF THE PRECISION MATRIX
Suppose we have k i.i.d. realizations, ∆1, ...,∆k, from the Wishart distri-
bution given in model (2.5). The corresponding log-likelihood can be com-
puted straight-forwardly:
`(Θ|∆1, ...,∆k) =
k∑
i=1
log
∣∣Θ∣∣− ν2
2−
vp
2 Γp
(
ν
2
) |∆i| ν−p−12 e− 12 tr(Θ−1∆i)
= c+
k∑
i=1
(
−ν
2
log
∣∣Θ∣∣− 1
2
tr
(
Θ−1∆i
))
= c− νk
2
(
log |Θ|+ tr
(
Θ−1
1
νk
k∑
i=1
∆i
))
.
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The last expression is to be maximized with respect to Θ and can be recog-
nized as the MLE problem in a multivariate Gaussian distribution. Hence,
Θ = 1kν
∑k
i=1 ∆i, is the MLE in this model.
APPENDIX E: APPROXIMATE MLE
To find the maximizing parameters we differentiate (2.3) w.r.t. Ψ and
equate to zero while assuming ν known and constant. The first order deriva-
tive can be seen in equation (C.2). Equating to zero yields
0 =
kν
2
Ψ−1 −
k∑
i=1
ν + ni
2
(Ψ + S′i)
−1(E.1)
=
kν
2
Ψ−1 −
k∑
i=1
ν + ni
2
(
I + Ψ−1Si
)−1
Ψ−1.
This implies kνI−∑ki=1(ν+ni) (I − (−Ψ−1Si))−1 = 0 which can be rewrit-
ten as
kνI −
k∑
i=1
(ν + ni)
∞∑
l=0
(−Ψ−1Si)l = 0,
by the Neumann series
(
(I +A)−1 =
∑∞
l=0A
l
)
provided that liml→∞(I −
Ψ−1Si)l = 0 for all i. This holds if the eigenvalues of Ψ−1Si are less than
1. We approximate by the first order expansion (l = 1), and
0 = kνI −
k∑
i=1
(ν + ni)(I −Ψ−1Si) = −n•I + Ψ−1
k∑
i=1
(ν + ni)Si
where n• =
∑k
i=1 ni is the total number of observations. This implies
Ψ−1
k∑
i=1
(ν + ni)Si = n•I
which suggests the estimators
ΨˆMLE =
∑k
i=1(ν + ni)Si
n•
and ΣˆMLE =
∑k
i=1(ν + ni)Si
(ν − p− 1)n• .(E.2)
These estimates are seen to correspond to a weighted sum of the scatter
matrices.
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APPENDIX F: DERIVATION OF ICC
Consider observations from (2.1). We temporarily abuse our notation and
let
Σ ∼ W−1p (Ψ, ν) and S|Σ ∼ Wp(Σ, 1),
and consider only a single observation (n = 1). Furthermore, let S =
(Sij)p×p, Σ = (Σij)p×p, and Ψ = (Ψij)p×p. To compute the ICC, we are
thus interested in the ratio of the quantities Var(Σij) and Var(Sij) corre-
sponding to the between-study and total variation of the covariance between
variables i and j, respectively. That is, the ICC is the proportion of the total
variance between studies,
ICC(ν) =
Var(Σij)
Var(Sij)
=
Var(Σij)
Var(Σij) + E[Var(Sij |Σ)] ,(F.1)
where the second equality is obtained by E[Sij |Σ] = Σij and the law of total
variation. This equality agrees with the usual ICC as E[Var(Sij |Σij)] can be
interpreted as the (expected) within-study variation. Using the conditional
variance given by Var(Sij |Σ) = Σ2ij + ΣiiΣjj the needed quantities can be
found. To compute an expression for (F.1) we need to consider the fourth-
order moments of the observations. From the model, known results of the
inverse Wishart distribution, cf. (Cook and Forzani, 2011; von Rosen, 1988),
leads to
Cov(Σij ,Σkl) =
2ΨijΨkl + (ν−p−1)
(
ΨikΨjl + ΨilΨkj
)
(ν − p)(ν − p− 1)2(ν − p− 3) , ν > p+ 3,(F.2)
implying that
Var(Σij) = Cov(Σij ,Σij) =
(ν − p+ 1)Ψ2ij + (ν − p− 1)ΨiiΨjj
(ν − p)(ν − p− 1)2(ν − p− 3) .(F.3)
Continuing with the expected conditional variance of Sij |Σ in the denomi-
nator of (F.1),
E
[
Var(Sij |Σij)
]
= Var(Σij) + E[Σij ]2 + Cov(Σii,Σjj) + E[Σii]E[Σjj ]
= Var(Σij) + Cov(Σii,Σjj) + (ν − p− 1)−2(Ψ2ij + ΨiiΨjj).(F.4)
An expression of Var(Sij) in terms of the elements of Ψ can then found by
substituting (F.2) and (F.3) into (F.4) and by extension an expression for
the ICC (F.1) can be obtained. We omit this tedious calculation which can
be verified to yield ICC(ν) = 1/(ν − p) as given in (2.7)
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